DNA‐mediated UCP1 overexpression in adipose tissue: A promising anti‐obesity gene therapy
Clinical and Translational Medicine · 2025
DOI: 10.1002/ctm2.70491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Ze-Wei Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Medicine, Sun Yat-sen University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Uncoupling Protein 1, Genetic Therapy, Obesity, Adipose Tissue. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund of Shenzhen Key Laboratory of Systems Medicine, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Background
Obesity has emerged as a global health challenge. Although GLP‐1 receptor agonists are showing considerable promise in weight loss, their clinical utility is partly limited by gastrointestinal adverse reactions and non‐fat weight loss side effects. UCP1‐mediated adipose thermogenesis is a critical process for body temperature maintenance and weight management. However, the lack of effective and specific adipose thermogenesis therapies has restricted its clinical application. We aimed to explore the potential of inducing adipose‐specific UCP1 overexpression via modified plasmids as an innovative therapeutic approach for obesity.
Methods
We replaced the cytomegalovirus (CMV) promoter in the plasmids with two types of adipose‐specific promoters: mouse adiponectin (mADP) promoter and human adiponectin (hADP) promoter, to selectively overexpress UCP1 in adipocytes. The expression level of UCP1, weight loss, metabolic homeostasis and adipose thermogenesis effects were evaluated by immunohistochemistry, western blot, weight measurements, thermography, and comprehensive lab animal monitoring system.
Results
The experiments demonstrated that the mADP promoter‐modified plasmids failed to drive UCP1 overexpression. In contrast, the hADP promoter‐modified Ucp1 overexpression (hADP‐ Ucp1 OE) plasmids achieved robust adipose‐specific UCP1 protein expression both in vitro and in vivo. In vitro experiments revealed that delivery of the hADP promoter‐modified UCP1 overexpression (hADP‐ UCP1 OE) plasmids reduced lipid droplet size and enhanced energy consumption in human adipocytes. In obese mice, administration of the hADP‐ Ucp1 OE plasmids resulted in significant weight loss and improved metabolic homeostasis.
Conclusions
These findings highlight the therapeutic potential of hADP‐ UCP1 OE plasmids in obesity management. Key points The hADP promoter‐modified plasmids selectively overexpress protein in adipose tissue. Overexpression of UCP1 driven by hADP promoter induces thermogenesis in mouse and human adipocytes in vitro. The hADP‐ Ucp1 OE treatment promotes thermogenesis and energy expenditure in mice. The hADP‐ Ucp1 OE treatment restrains the development of obesity and glucose intolerance in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, School of Medicine, Sun Yat-sen University, Shenzhen, Guangdong, China.
- Department of Geriatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
ORCID-Profile: Ze-Wei Zhao, Zhonghan Yang
Förderung
- Fund of Shenzhen Key Laboratory of Systems Medicine
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhao, Z. W., Hu, L., Song, B., Wu, Q., Lin, J., Liu, Q., Liu, S., Li, J., Wang, M., Li, J., & Yang, Z. (2025). DNA‐mediated UCP1 overexpression in adipose tissue: A promising anti‐obesity gene therapy. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70491
Vancouver
Zhao ZW, Hu L, Song B, Wu Q, Lin J, Liu Q, et al. DNA‐mediated UCP1 overexpression in adipose tissue: A promising anti‐obesity gene therapy. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70491
BibTeX
@article{Zhao2025,
author = {Zhao, Ze-Wei and Hu, Longyun and Song, Bigui and Wu, Qian and Lin, Jiejing and Liu, Qingqing and Liu, Siqi and Li, Jin and Wang, Molin and Li, Jin and Yang, Zhonghan},
title = {DNA‐mediated UCP1 overexpression in adipose tissue: A promising anti‐obesity gene therapy},
journal = {Clinical and Translational Medicine},
year = {2025},
doi = {10.1002/ctm2.70491}
}
EUVIMED